Different Serum Enzyme Levels Are Required to Rescue the Various Systemic Features of the Mucopolysaccharidoses

Does enzyme replacement therapy influence the ocular changes in type VI mucopolysaccharidosis?

(2009) Susanne Pitz et al.   GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY

On the biomechanics of heart valve function

(2009) Michael S. Sacks et al.   JOURNAL OF BIOMECHANICS

Simvastatin therapy in cyclosporine A-induced alveolar bone loss in rats

(2008) P. O. Nassar et al.   JOURNAL OF PERIODONTAL RESEARCH

The role of macrophage in the pathogenesis of chronic cyclosporine-induced nephropathy

(2008) J. Y. Ghee et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Long-term follow-up of a girl with Maroteaux-Lamy syndrome after bone marrow transplantation

(2008) Ching-Chia Wang et al.   World Journal of Pediatrics

Reversed papilledema in an MPS VI patient with galsulfase (Naglazyme®) therapy

(2008) Selim T. Koseoglu et al.   INTERNATIONAL OPHTHALMOLOGY

Biochemical, Pathological, and Skeletal Improvement of Mucopolysaccharidosis VI After Gene Transfer to Liver but Not to Muscle

(2007) Alessandra Tessitore et al.   MOLECULAR THERAPY